High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges | Zendy

Anton W. Langerak | Zendy; Monika Brüggemann | Zendy; Frédéric Davi | Zendy; Nikos Darzentas | Zendy; Jacques J. M. van Dongen | Zendy; David González | Zendy; Giovanni Cazzaniga | Zendy; Véronique Giudicelli | Zendy; MariePaule Lefranc | Zendy; Mathieu Giraud | Zendy; Elizabeth Macintyre | Zendy; Michael Hummel | Zendy; Christiane Pott | Zendy; Patricia J.T.A. Groenen | Zendy; Κώστας Σταματόπουλος | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges

Author(s) -

Anton W. Langerak,

Monika Brüggemann,

Frédéric Davi,

Nikos Darzentas,

Jacques J. M. van Dongen,

David González,

Giovanni Cazzaniga,

Véronique Giudicelli,

MariePaule Lefranc,

Mathieu Giraud,

Elizabeth Macintyre,

Michael Hummel,

Christiane Pott,

Patricia J.T.A. Groenen,

Κώστας Σταματόπουλος

Publication year - 2017

Publication title -

the journal of immunology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.737

H-Index - 372

eISSN - 1550-6606

pISSN - 0022-1767

DOI - 10.4049/jimmunol.1602050

Subject(s) - computational biology , workflow , throughput , dna sequencing , computer science , biology , gene , genetics , database , telecommunications , wireless

Analysis and interpretation of Ig and TCR gene rearrangements in the conventional, low-throughput way have their limitations in terms of resolution, coverage, and biases. With the advent of high-throughput, next-generation sequencing (NGS) technologies, a deeper analysis of Ig and/or TCR (IG/TR) gene rearrangements is now within reach, which impacts on all main applications of IG/TR immunogenetic analysis. To bridge the generation gap from low- to high-throughput analysis, the EuroClonality-NGS Consortium has been formed, with the main objectives to develop, standardize, and validate the entire workflow of IG/TR NGS assays for 1) clonality assessment, 2) minimal residual disease detection, and 3) repertoire analysis. This concerns the preanalytical (sample preparation, target choice), analytical (amplification, NGS), and postanalytical (immunoinformatics) phases. Here we critically discuss pitfalls and challenges of IG/TR NGS methodology and its applications in hemato-oncology and immunology.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research